Prosecution Insights
Last updated: October 04, 2026

Dechra Limited

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Dechra Limited holds a company patent portfolio with 1 pending office action currently on record. This 1 pending office action is being handled by 1 distinct examiner. The data shows 0 distinct art units, indicating that the pending application is not currently associated with a specific art unit in this dataset. This absence of a distinct art unit classification simplifies the departmental landscape but limits the available context for the prosecution.

CHANDRA, GYAN is the busiest examiner for the portfolio, overseeing 1 busiest examiner pending office action. Since there is only 1 pending office action in the entire portfolio, this examiner is the sole point of contact for the company's active matters. The 1 to 1 ratio of examiners to pending actions highlights a lack of distribution in the current examination process. The 0 distinct art units mean the prosecution is not tied to a specific unit's reported standards.

For a patent practitioner, the 1 distinct examiner represents the only active hurdle for the company's current filings. The success of the 1 pending office action depends on the specific review by CHANDRA, GYAN. Without any distinct art units, the strategy must be tailored specifically to the examiner's individual requirements.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHANDRA, GYAN 1 71.3% +27.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18581048 ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE CHANDRA, GYAN —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18581048 ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE CHANDRA, GYAN — §112DP Non-Final OA — Pending Feb 19, 2024

Managing Dechra Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month